Mechanisms For PPARdelta Agonist-Induced Elevation of HDL in Non-Human Primates
Mechanisms For PPARdelta Agonist-Induced Elevation of HDL in Non-Human Primates
批准号:
7769906
负责人:
Ryan Eugene Temel
金额:
$24.77万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-15 至 2012-01-31
关键词:
AddressAdipose tissueAffectAgonistAntisense OligonucleotidesApolipoproteinsApolipoproteins ABindingCatabolismCause of DeathCercopithecus pygerythrusCessation of lifeCholesterolCholesterol Ester Transfer ProteinsDataDevelopmentDiseaseEngineeringGene ExpressionGenesHeart DiseasesHepaticHigh Density Lipoprotein CholesterolHigh Density LipoproteinsHuman Cell LineHuman bodyIntestinesLecithinLipaseLiverMediatingMentorsMessenger RNAMetabolicMetabolismMonkeysMusMuscleOrganPPAR deltaPharmaceutical PreparationsPhasePhenotypePhosphatidylcholine-Sterol O-AcyltransferasePhospholipid Transfer ProteinsPlasmaPrimatesProductionProteinsRiskRoleSamplingSiteSmall IntestinesSpecificitySterol O-AcyltransferaseTestingTherapeuticTransferaseUnited StatesWomanbaseheart disease riskhepatic lipasein vitro Assayin vivoinsightlipid transfer proteinlipoprotein lipasemennonhuman primatepreventprotein expressiontherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
RedudionjofLDL-cholesterol through the: use;q^
mprtality and n(i6rb)<3ity caused by GO ro disease (GHD), Nevertheless, GHD remains the leading
caijse of: death fbrnnen and vfi¿3men in the United Stat^, OneireasQfi for the persistence of CHD may be the
tacfebf:therapies'that;)riqrease;:(HE)L-chQieste^ ¿lt'is:wiBll'established:that.,l-iDL-d'conGertti¿!tion is-a'^
stripng,ihdeipendentjnver^ely^^^m^ Because of data Indicating that a 1 mg/dl
increase in HDL.-C decreases CHD risk; by ^^^^
therapiesiihdt'yyili'.ieffe'diWjy.iele^ <3ri6 class''ibif'Comfiounds::that;'may have.great;"
therapeutic potential are PHARd agonists, which in non'human primates can elevate HDLrG by 43-79% and
apo/V-1, themajor apolipoprotein of HiDL, by 43i%. Irt this applicatiprv, j prpposetpdeflne;the mechanisms by
which PPARftagtjhlstsiriGiuceHpL-G elevation in non-liymari primates, twill deteriTiine whether PPARS
agonists increase HDL-G by: 1) altering HDL production or catabolism; 2) changing the activity of plasma
ITpasiis, lipid transfer proteins, and LGAT; 3) mpdolating themRNA and protein expression of genes involved
in HDL metabolism. In addition, I pnoppse to determine whether PPAR6 agonists elevate HDL-C in monkeys
that have Ibeen treated with antisense oligonudeptides that suppress hepatic expression of ATP binding
cass|0e,trarispdrter A;^ .iCAS'C^
deN^loprhisfit of rnbre-potent PPAR6 agbnlsts or other therapiesthateffeetiveiy increase HbL-C. which in
turn could prevent CHD in hundreds of thousands pf people each year in the Onlted Statisss and around the
world.
Scientific data indicates that inGreasing HDL choiasterol may decree
cause of death for men arid women in the United States. We propose to determine the mechanisms by
which a new class of drugs, known as RPAR;delta agonists, increase HDL-Ghdlesterolin monkeys. Because
of the high cjegr^ of similality between the bodies of
studies \yillproyideinsighlsf6i'the development of therapieis that could increase HDL and prevent the deaths
of iiuhdreds of thousands of ;people each year from heart disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting microRNA-33 to reduce intracranial atherosclerosis and other neurovascular hallmarks of vascular cognitive impairment and dementia
-
批准号:9765860
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2019
-
负责人:Ryan Eugene Temel
-
依托单位:
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
-
批准号:8438869
-
项目类别:
-
资助金额:$71.51万
-
财政年份:2013
-
负责人:Ryan Eugene Temel
-
依托单位:
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
-
批准号:8968259
-
项目类别:
-
资助金额:$71.39万
-
财政年份:2013
-
负责人:Ryan Eugene Temel
-
依托单位:
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
-
批准号:8774254
-
项目类别:
-
资助金额:$72.5万
-
财政年份:2013
-
负责人:Ryan Eugene Temel
-
依托单位:
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
-
批准号:9352511
-
项目类别:
-
资助金额:$5.4万
-
财政年份:2013
-
负责人:Ryan Eugene Temel
-
依托单位:
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
-
批准号:9181440
-
项目类别:
-
资助金额:$72.12万
-
财政年份:2013
-
负责人:Ryan Eugene Temel
-
依托单位:
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
-
批准号:8605546
-
项目类别:
-
资助金额:$71.67万
-
财政年份:2013
-
负责人:Ryan Eugene Temel
-
依托单位:
Mechanisms For PPARdelta Agonist-Induced Elevation of HDL in Non-Human Primates
-
批准号:8018108
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2009
-
负责人:Ryan Eugene Temel
-
依托单位:
Mechanisms For PPARdelta Agonist-Induced Elevation of HDL in Non-Human Primates
-
批准号:7760739
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:Ryan Eugene Temel
-
依托单位:
Mechanisms For PPARdelta Agonist-Induced Elevation of HDL in Non-Human Primates
-
批准号:7250977
-
项目类别:
-
资助金额:$8.77万
-
财政年份:2006
-
负责人:Ryan Eugene Temel
-
依托单位:
Mechanisms For PPARdelta Agonist-Induced Elevation of HDL in Non-Human Primates
-
批准号:7323264
-
项目类别:
-
资助金额:$8.57万
-
财政年份:2006
-
负责人:Ryan Eugene Temel
-
依托单位:
海外基金